Gilead Sciences Publishes 2023 ESG Impact Report
Gilead Sciences Publishes 2023 ESG Impact Report
NORTHAMPTON, MA / ACCESSWIRE / April 18, 2024 / Gilead Sciences published its 2023 Environmental, Social and Governance (ESG) Impact Report, which uses the ESG framework to highlight the successes and achievements of the prior year.
馬薩諸塞州北安普敦/ACCESSWIRE/2024年4月18日/吉利德科學發佈了2023年環境、社會和治理（ESG）影響報告，該報告使用ESG框架重點介紹了前一年的成功和成就。
In this year's report, you will see examples of Gilead's impact across four pillars:
在今年的報告中，您將看到吉利德對四大支柱的影響的示例：
- Innovating Scientific Solutions
- Advancing Health Equity and Access
- Empowering People and Communities
- Sustaining Our Shared Planet
- 創新科學解決方案
- 促進健康公平和可及性
- 賦予人們和社區權力
- 維護我們共同的星球
Learn how we're advancing our vision to create a healthier world while benefiting our people, the communities we support and our planet.
了解我們如何推進願景，創造一個更健康的世界，同時造福我們的人民、我們支持的社區和我們的地球。
Gilead Sciences
吉利德科學
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead Sciences, Inc. 是一家以研究爲基礎的生物製藥公司，在醫療需求未得到滿足的領域發現、開發和商業化創新藥物。該公司致力於改變和簡化對世界各地患有危及生命的疾病患者的護理。吉利德在全球超過35個國家開展業務，總部位於加利福尼亞州福斯特城。
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
在 3blmedia.com 上查看吉利德科學提供的更多多媒體和更多 ESG 故事。
Contact Info:
Spokesperson: Gilead Sciences
聯繫信息：
發言人：吉利德科學
SOURCE: Gilead Sciences
來源：吉利德科學
譯文內容由第三人軟體翻譯。